ReviewFrontiers in oncology2026
Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alkaloids as Emerging Neuroprotective Agents for Neurodegenerative Disorders: Insights into Tryptanthrin and Its Derivatives.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer, the second leading cause of death worldwide, has prompted extensive research to uncover its mechanisms and identify effective prognostic and therapeutic strategies. Deregulation of microRNAs (miRNAs) contributes to the abnormal activation of tumorigenic processes and repression of tumor-suppressive mechanisms across various cancer types. Plants biosynthesize a wide range of structurally diverse secondary metabolites with outstanding medicinal applications. Despite notable advancements in cancer therapeutics, the current anticancer drugs and treatment approaches have not achieved complete effectiveness. The literature indicates that alkaloids and their derivatives possess strong anticancer potential and have emerged as promising pharmacological agents. Numerous alkaloids screened from herbal (medicinal) sources have demonstrated significant antiproliferative and anticancer effects against several cancer types. Numerous anticancer drugs derived from alkaloids, including vindesine, vinblastine, vincristine, and vinorelbine, have been developed and are widely used in cancer therapeutics. Research has also shown that the alkaloid regulates miRNA expression, thereby inhibiting cancer cell invasion and migration, and leading to apoptosis induction. This review comprehensively evaluated the role of alkaloids in regulating miRNA expression and their downstream targets involved in cancer progression, metastasis, and chemoresistance in various carcinomas. We highlight how miRNAs function as key regulators and mediators of the anticancer mechanisms of these natural compounds. Furthermore, we have also summarized the potent role of different types of miRNAs in cancer progression and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.